Merck’s HIV prevention pill: could it be made for under $5 a year? Merck is developing an experimental oral HIV prevention medicine, and a new analysis suggests it could be manufactured for less than $5 per patient per year . The estimate is positioned as a feasibility target for mass production ,…
Continue reading...
Continue reading...